ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 372 filers reported holding ASTRAZENECA PLC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,460 | -5.4% | 5,500 | 0.0% | 0.12% | +2.5% |
| Q2 2023 | $393,635 | +3.1% | 5,500 | 0.0% | 0.12% | +8.0% |
| Q1 2023 | $381,755 | +2.4% | 5,500 | 0.0% | 0.11% | -3.4% |
| Q4 2022 | $372,900 | +23.5% | 5,500 | 0.0% | 0.12% | +16.0% |
| Q3 2022 | $302,000 | -16.8% | 5,500 | 0.0% | 0.10% | -12.3% |
| Q2 2022 | $363,000 | -0.5% | 5,500 | 0.0% | 0.11% | +17.5% |
| Q1 2022 | $365,000 | +14.1% | 5,500 | 0.0% | 0.10% | +22.8% |
| Q4 2021 | $320,000 | -3.0% | 5,500 | 0.0% | 0.08% | -13.2% |
| Q3 2021 | $330,000 | +0.3% | 5,500 | 0.0% | 0.09% | -8.1% |
| Q2 2021 | $329,000 | +20.5% | 5,500 | 0.0% | 0.10% | +15.1% |
| Q1 2021 | $273,000 | +56.0% | 5,500 | +57.1% | 0.09% | +48.3% |
| Q4 2020 | $175,000 | -8.9% | 3,500 | 0.0% | 0.06% | -14.7% |
| Q3 2020 | $192,000 | +3.8% | 3,500 | 0.0% | 0.07% | -2.9% |
| Q2 2020 | $185,000 | +18.6% | 3,500 | 0.0% | 0.07% | +1.4% |
| Q1 2020 | $156,000 | -21.6% | 3,500 | -12.5% | 0.07% | -5.5% |
| Q4 2019 | $199,000 | +11.8% | 4,000 | 0.0% | 0.07% | +9.0% |
| Q3 2019 | $178,000 | +7.9% | 4,000 | 0.0% | 0.07% | +6.3% |
| Q2 2019 | $165,000 | +1.9% | 4,000 | 0.0% | 0.06% | -1.6% |
| Q1 2019 | $162,000 | +6.6% | 4,000 | 0.0% | 0.06% | -7.2% |
| Q4 2018 | $152,000 | -3.8% | 4,000 | 0.0% | 0.07% | +15.0% |
| Q3 2018 | $158,000 | +12.9% | 4,000 | 0.0% | 0.06% | +5.3% |
| Q2 2018 | $140,000 | -27.1% | 4,000 | -27.3% | 0.06% | -28.8% |
| Q1 2018 | $192,000 | +0.5% | 5,500 | 0.0% | 0.08% | +3.9% |
| Q4 2017 | $191,000 | +2.7% | 5,500 | 0.0% | 0.08% | -1.3% |
| Q3 2017 | $186,000 | -0.5% | 5,500 | 0.0% | 0.08% | +2.6% |
| Q2 2017 | $187,000 | -7.4% | 5,500 | -15.4% | 0.08% | -13.6% |
| Q1 2017 | $202,000 | +9.8% | 6,500 | -3.7% | 0.09% | +3.5% |
| Q4 2016 | $184,000 | -25.8% | 6,750 | -10.6% | 0.08% | -26.1% |
| Q3 2016 | $248,000 | +8.8% | 7,550 | 0.0% | 0.12% | +8.5% |
| Q2 2016 | $228,000 | -7.3% | 7,550 | -13.7% | 0.11% | -11.7% |
| Q1 2016 | $246,000 | -29.3% | 8,750 | -14.6% | 0.12% | -28.1% |
| Q4 2015 | $348,000 | +6.7% | 10,250 | 0.0% | 0.17% | +2.5% |
| Q3 2015 | $326,000 | -8.9% | 10,250 | +82.2% | 0.16% | +1.2% |
| Q2 2015 | $358,000 | -21.0% | 5,625 | -15.1% | 0.16% | -19.5% |
| Q1 2015 | $453,000 | -12.7% | 6,625 | -10.2% | 0.20% | -13.0% |
| Q4 2014 | $519,000 | -36.7% | 7,375 | -35.7% | 0.23% | -39.5% |
| Q3 2014 | $820,000 | +52.7% | 11,475 | +58.8% | 0.38% | +51.4% |
| Q2 2014 | $537,000 | +416.3% | 7,225 | +351.6% | 0.25% | +422.9% |
| Q1 2014 | $104,000 | 0.0% | 1,600 | -8.6% | 0.05% | 0.0% |
| Q4 2013 | $104,000 | – | 1,750 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |